808 filings
Page 26 of 41
8-K
TGTX
TG Therapeutics, Inc.
26 May 11
Other Events
12:00am
8-K
TGTX
TG Therapeutics, Inc.
24 May 11
Submission of Matters to a Vote of Security Holders
12:00am
10-Q
2011 Q1
TGTX
TG Therapeutics, Inc.
Quarterly report
16 May 11
12:00am
10-K
2010 FY
TGTX
TG Therapeutics, Inc.
Annual report
31 Mar 11
12:00am
DEF 14A
TGTX
TG Therapeutics, Inc.
Definitive proxy
22 Mar 11
12:00am
UPLOAD
TGTX
TG Therapeutics, Inc.
21 Mar 11
Letter from SEC
12:00am
CORRESP
TGTX
TG Therapeutics, Inc.
14 Mar 11
Correspondence with SEC
12:00am
8-K/A
TGTX
TG Therapeutics, Inc.
11 Mar 11
Entry into a Material Definitive Agreement
12:00am
UPLOAD
TGTX
TG Therapeutics, Inc.
8 Mar 11
Letter from SEC
12:00am
8-K
TGTX
TG Therapeutics, Inc.
7 Mar 11
Entry into a Material Definitive Agreement
12:00am
PRE 14A
TGTX
TG Therapeutics, Inc.
Preliminary proxy
1 Mar 11
12:00am
8-K
TGTX
TG Therapeutics, Inc.
14 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
TGTX
TG Therapeutics, Inc.
31 Jan 11
Manhattan Pharmaceuticals Achieves Ariston Merger Milestone
12:00am
SC 13D/A
Nordic Biotech Venture Fund II K/S
24 Jan 11
MANHATTAN PHARMACEUTICALS / Nordic Biotech Venture Fund II K/S ownership change
12:00am
8-K
TGTX
TG Therapeutics, Inc.
10 Jan 11
Manhattan Pharmaceuticals Announces Entry into Settlement and Release Agreement with Nordic Biotech
12:00am
8-K
TGTX
TG Therapeutics, Inc.
4 Jan 11
Departure of Directors or Certain Officers
12:00am
10-Q
2010 Q3
TGTX
TG Therapeutics, Inc.
Quarterly report
15 Nov 10
12:00am
8-K
TGTX
TG Therapeutics, Inc.
8 Nov 10
Manhattan Pharmaceuticals Awarded $245K Grant under the U.S. Qualified Therapeutic Discovery Project Credit Program
12:00am
8-K
TGTX
TG Therapeutics, Inc.
13 Oct 10
Regulation FD Disclosure
12:00am
SC 13D/A
Nordic Biotech Venture Fund II K/S
23 Sep 10
MANHATTAN PHARMACEUTICALS / Nordic Biotech Venture Fund II K/S ownership change
12:00am